Nathan Steven D, Kim Ho Cheol, King Christopher S, Aryal Shambhu, Thomas Christopher, Kattih Zein, Shlobin Oksana A, Khangoora Vikramjit, Chandel Abhimanyu
Advanced Lung Disease and Transplant Program, Inova Heart and Vascular Institute, Inova Fairfax Hospital, Falls Church, Virginia.
Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; and.
Am J Respir Crit Care Med. 2025 Jun;211(6):984-991. doi: 10.1164/rccm.202411-2157OC.
Pulmonary hypertension (PH) commonly complicates idiopathic pulmonary fibrosis (IPF). However, the rate of change in pulmonary hemodynamics in IPF remains poorly defined. To examine the rate of change in pulmonary hemodynamics among patients with IPF. The rate of change in mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR) was examined in patients with IPF listed for lung transplantation. The fifth and seventh World Symposium on Pulmonary Hypertension definitions for precapillary PH were used in this analysis. There were 496 patients with IPF who had at least two right heart catheterizations (RHCs) while listed for lung transplantation. The median time between repeated RHCs was 9 months (interquartile range [IQR], 6 to 14 mo). PH was present in 25.8% and 46.8% at the first RHC, whereas 42.9% and 64.3% had PH by the two definitions, respectively, at the time of the final RHC. The median rate of change in the mPAP and PVR were 3.8 mm Hg/yr (IQR, -0.9 to 11.8) and 0.8 Wood units/yr (IQR, -0.2 to 2.4), respectively. The rate of PVR change was slower for those with established PH than those without PH. A total of 28.6% of the patients had accelerated progression of their hemodynamics, arbitrarily defined as an increase in PVR of ⩾2 Wood units/yr. PH associated with IPF tends to progress in an unpredictable fashion, with some patients demonstrating an accelerated phenotype. Among patients with RHC hemodynamics below the threshold for therapy, close vigilance is warranted, with consideration for an early repeat RHC.
肺动脉高压(PH)常并发特发性肺纤维化(IPF)。然而,IPF患者肺血流动力学的变化率仍不清楚。为了研究IPF患者肺血流动力学的变化率。对列入肺移植名单的IPF患者的平均肺动脉压(mPAP)和肺血管阻力(PVR)的变化率进行了研究。本分析采用第五届和第七届世界肺动脉高压研讨会关于毛细血管前PH的定义。有496例IPF患者在列入肺移植名单期间至少进行了两次右心导管检查(RHC)。重复RHC之间的中位时间为9个月(四分位间距[IQR],6至14个月)。在首次RHC时,PH的发生率分别为25.8%和46.8%,而在最后一次RHC时,根据两种定义分别有42.9%和64.3%的患者患有PH。mPAP和PVR的中位变化率分别为3.8 mmHg/年(IQR,-0.9至11.8)和0.8 Wood单位/年(IQR,-0.2至2.4)。已确诊PH的患者的PVR变化率比未患PH的患者慢。共有28.6%的患者血流动力学进展加速,任意定义为PVR增加≥2 Wood单位/年。与IPF相关的PH往往以不可预测的方式进展,一些患者表现出加速进展的表型。在RHC血流动力学低于治疗阈值的患者中,有必要密切监测,并考虑早期重复进行RHC。